REPL Stock | | | USD 14.93 3.88 35.11% |
This module uses fundamental data of Replimune to approximate its Piotroski F score. Replimune F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Replimune Group. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Replimune financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Replimune Altman Z Score,
Replimune Correlation,
Replimune Valuation, as well as analyze
Replimune Alpha and Beta and
Replimune Hype Analysis.
At this time, Replimune's
Debt Equity Ratio is quite stable compared to the past year.
Debt Ratio is expected to rise to 0.10 this year, although the value of
Long Term Debt will most likely fall to about 24.7
M. At this time, Replimune's
Interest Debt Per Share is quite stable compared to the past year.
Debt To Assets is expected to rise to 0.10 this year, although the value of
Free Cash Flow Yield is projected to rise to
(0.35).
At this time, it appears that Replimune's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Unavailable
| Current Return On Assets | Negative | Focus |
| Change in Return on Assets | Decreased | Focus |
| Cash Flow Return on Assets | Negative | Focus |
| Current Quality of Earnings (accrual) | Improving | Focus |
| Asset Turnover Growth | No Change | Focus |
| Current Ratio Change | Increase | Focus |
| Long Term Debt Over Assets Change | Lower Leverage | Focus |
| Change In Outstending Shares | Decrease | Focus |
| Change in Gross Margin | No Change | Focus |
Replimune Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Replimune is to make sure Replimune is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Replimune's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Replimune's financial numbers are properly reported.
Replimune Group F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Replimune's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Replimune in a much-optimized way.
Click cells to compare fundamentals
About Replimune Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Replimune ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Replimune's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Replimune's managers, analysts, and investors.
About Replimune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Replimune Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Replimune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Replimune Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectWhen determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's
future performance.
For an informed investment choice regarding Replimune Stock, refer to the following important reports: Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets | Return On Equity |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine
if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.